CURRENT ISSUE Current Issue Cover
VOL 5 • NUMBER 5 SEP/OCT
IN THIS ISSUE

Modifiable Risk Factors Affecting Outcomes: The Truth About Obesity

Pamela Hallquist Viale, RN, MS, CS, ANP

Treatment Considerations for the Management of Patients With Hormone Receptor–Positive Metastatic Breast Cancer

Constance Visovsky, PhD, RN, ACNP-BC

Improving Palliative Cancer Care

Catherine Del Ferraro, MSN, ED, PHN, RN, CCRP, Betty Ferrell, PhD, FAAN, MA, FPCN, CHPN, Carin Van Zyl, MD, FACEP, Bonnie Freeman, DNPC, RN, ANP-BC, and Linda Klein, JD

Using Technology to Advance Cancer Survivorship Programs

Mark Fosdal, RN, PA-C, DHSc

More Articles More Articles
 
Section Seperator

TODAY'S NEWS

Neratinib Plus Capecitabine Shows Activi...

Neratinib is an irreversible pan-tyrosine kinase i...

Increase in PSA Levels 5 to 10 Years Aft...

A new study shows that at least 9.1% and 15.6% of ...

Oncologist Participation in Tumor Board ...

A new population-based study of close to 5,000 pat...

Medicare Part D Low-Income Subsidy Progr...

Findings from a study of more than 23,000 women su...

Death of Patients Within 1 Month of Canc...

In a study of more than 1.1 million patients who u...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Ibrutinib in Lymphoma and Leukemia

Targeted scientific advancements have produced novel therapies and made significant improvements...

Clinical Management of Pancreatic Cancer

Pancreatic cancer is the fourth leading cause of cancer deaths in the United States...

Use of Radiographic Criteria to Predict Outcomes

Surgical resection of the pancreas is the only treatment...

Human Herpesvirus-6 Encephalitis After Stem Cells

Mrs. L. was in good health until she was diagnosed with...

Cancer Prediction Nomograms for APs

Cancer prediction nomograms provide APs with tools...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Having Dependent Children Motivates Pare...

Findings from a pilot study of 42 parents with adv...

FDA Grants Lenvatinib Priority Review De...

The U.S. Food and Drug Administration (FDA) has ac...

FDA Approves Expanded Use of Tilmanocept...

The U.S. Food and Drug Administration has approved...

Single-Day Education Program Mitigates P...

More women are undergoing salpingo-oophorectomy as...

Racial Differences in the Risk of Second...

Regardless of age at diagnosis, type of treatment,...

More Highlights More Highlights
Section Seperator

LATEST TWEETS

Breast Cancer Community Walk http://t.co/7Eqk...

about 1 minutes ago via web

In Tennessee, Time Comes for a Nuclear Pla...

about 2 minutes ago via web

RT @NPCindyCooke: APRNs routinely collabor...

about 5 minutes ago via web

4 Foods 4 #Longevity & #Diseases Free(...

about 5 minutes ago via web

Girl Scouts Debate Their Place in a Changi...

about 6 minutes ago via web

More Tweets More Tweets
 
Section Seperator
Section Seperator
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer